Secondary Care Webinar 2 – Best practice pharmacological treatment for hypertrophic cardiomyopathy – optimizing your patients’ care and integrating today’s treatment options (First schedule)

Course Overview

This content was accurate at the time of release, 23 April 2023. Accreditation for this course expired on 23 May 2023. If you would still like an activity completion certificate, send your request to [email protected].

This event will take place twice on April 24th, 2023
First schedule: 1pm EDT / 7pm CEST
Second schedule: 7pm EDT / 1am CEST (+1)

This expert webinar is designed to improve knowledge around pharmaceutical treatments available for HCM management. It assists secondary healthcare professionals to:

  • categorize patients into obstructive versus non-obstructive HCM and select appropriate management strategy
  • integrate the latest pharmaceutical treatments for HCM into management strategies

This webinar is 60 minutes duration.

Target audience

Cardiologists, echocardiographers, electrophysiologists, cardiac sonographers, cardiology nurses, nurse practitioners, registered nurses, physician assistants, pediatricians, pediatric nurses.

Funding disclosure

This activity is supported by educational grant funding from Bristol Myers Squibb and Cytokinetics. Learners may participate in this educational activity free of charge.

  • Welcome and introduction to obstructive versus non-obstructive HCM
  • Pharmaceutical treatment of obstructive HCM
  • Pharmaceutical treatment of non-obstructive HCM
  • Integrating newer therapies into current management scheme
  • Q&A and closing remarks​

By the end of this activity, attendees will be able to:

  • outline medications currently available for treatment of obstructive HCM
  • summarize medications currently available for treatment of nonobstructive HCM
  • outline appropriate management strategies for patients with HCM and how to modify them when symptoms are refractory to one line of treatment
  • explain how the latest pharmaceutical treatments for HCM can be integrated into current management practices

This continuing education (CE) activity is provided through collaboration between PCM Scientific and AffinityCE. This activity provides CE credit for physicians, physician assistants, nurses and nurse practitioners. A statement of participation is available to other attendees.  

Physicians 

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AffinityCE and PCM Scientific. AffinityCE is accredited by the ACCME to provide continuing medical education for physicians. 

AffinityCE designates this enduring activity for a maximum of up to 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Physician Assistants 

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AffinityCE and PCM Scientific. AffinityCE is accredited by the ACCME to provide continuing medical education for physicians. 

AffinityCE designates this enduring activity for a maximum of up to 1.0 AMA PRA Category 1 Credits™. Physician assistants should claim only the credit commensurate with the extent of their participation in the activity. 

Nurse Practitioners 

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AffinityCE and PCM Scientific. AffinityCE is accredited by the ACCME to provide continuing medical education for physicians. 

AffinityCE designates this enduring activity for a maximum of up to 1.0 AMA PRA Category 1 Credits™. Nurse practitioners should claim only the credit commensurate with the extent of their participation in the activity. 

Nurses 

Continuing Nursing Education is provided for this program through the joint providership between PCM Scientific and AffinityCE. AffinityCE is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation (ANCC). This activity provides a maximum of up to 1.0 contact hours of continuing nursing education credit. 

CME Inquiries 

For all CME policy-related inquiries, please contact us at [email protected] 

Dr Martin Maron​, MD, Director of the Hypertrophic Cardiomyopathy Center, Lahey Hospital, Burlington, Massachusetts​, US, has received financial compensation for consulting for Cytokinetics, Imbria, Edgewise Therapeutics, and received research grants from IRhythm Technologies.

Prof Iacopo Olivotto, MD, Head of the Cardiomyopathy Unit and Associate Professor of Cardiovascular Medicine, Careggi University Hospital, Florence, Italy​​, has received financial compensation for consulting for Bristol Myers Squibb, Cytokinetics, Sanofi Genzyme, Takeda Shire, Amicus Therapeutics, Menarini, Chiesi Farmaceutici, Astrazeneca, Novartis, and received research grants from Bristol Myers Squibb, Sanofi Genzyme, Takeda Shire, Amicus Therapeutics, Menarini, Chiesi Farmaceutici, Boston Scientific, Bayer, Daichi-Sankyo.

AffinityCE staff, PCM Scientific staff, as well as planners and reviewers have no relevant financial interests to disclose.

Mitigation of relevant financial relationships

AffinityCE adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CME activity, including faculty, planners, reviewers, or others, are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant financial relationships have been mitigated prior to the commencement of the activity.

  1. Please log in once registered, return to the individual course page and click ‘Start course’. 
  2. Take the Pre-learning test. This step is optional but helps us to understand how effective the courses are that we create. 
  3. Complete the learning activity (e.g, Live webinar or Case study) and when finished click the ‘Next step’ button underneath the content panel. 
  4. Complete the Post-learning test and click the ‘Submit answers’ button at the bottom of the test. This step is mandatory, and you must pass with ≥80% correct responses if you wish to earn CE credit(s).
    You may view your responses along with the correct answers and explanatory information after you submit by clicking ‘Review test answers’.
    You can re-take the test as many times as desired by clicking the ‘Re-take test’ button. 
  5. Complete the Course evaluation and click the ‘Submit answers’ button at the bottom of the page. You can complete this in part or in full but your responses help us to understand how effective the courses are that we create.
    Then click the ’Continue course’ button on the right of the page. 
  6. At the course completion stage, please click the ‘Confirm complete and request certificate’ button. 
  7. You can now download your CE credit certificate via the ‘Download Certificate’ button.  

If you need any help or assistance, please let us know at [email protected]. 

NOTE:  

You will have 30 days from the date of a Live webinar to complete steps 4–7. 

For all On-demand courses (e.g., Case study), you will be able to earn CE credit for a 12-month period. You will not be able to download a certificate after the CME expiry date.